Open AccessThe COLUMBUS Trial in Metastatic Melanoma—New Peer-Reviewed Data
Author(s) -
Omid Hamid
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000552828.59754.c4
Subject(s) - dabrafenib , trametinib , medicine , melanoma , oncology , metastatic melanoma , cancer , clinical trial , vemurafenib , targeted therapy , disease , mek inhibitor , cancer research , mapk/erk pathway , kinase , biology , microbiology and biotechnology